Limitations of Epidemiological and Serologic Studies Addressing Simian Virus 40 and Non-Hodgkin's Lymphoma

REFERENCES

• Engels E. A. Does simian virus 40 cause non-hodgkin's lymphoma? A review of the laboratory and epidemiological data. Cancer Invest. 2005; 23(6)529–536, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Stratton K., Almario D. A., McCormick M. C. Institute of Medicine of the National Academies. The National Academies Press, Washington, DC 2003, SV40 contamination of polio vaccine and cancer. Immunization Safety Review Committee, Board of Health Promotion and Disease Prevention
   Google Scholar
• Rollison D. E., Shah K. V. The epidemiology of SV40 infection due to contaminated polio vaccines: relation of the virus to human cancer. Human Polyomaviruses: Molecular and Clinical Perspectives, K. Khalili, G. L. Stoner. Wiley-Liss, Inc, New York 2001; 561–584
   Google Scholar
• Vilchez R. A., Kozinetz C. A., Butel J. S. Conventional epidemiology and the link of SV40 infections with human cancers. Lancet Oncol. 2003; 4(3)188–191, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vilchez R. A., Butel J. S. Emergent human pathogen simian virus 40 and its role in cancer. Clin. Microbiol. Rev. 2004; 17(3)495–508, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Barbantini-Brodano G., Corallini A., Acolla R. S., Martini F., Tognon M. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J. Natl. Cancer. Inst. 2004; 96(10)803–804, [CSA]
   PubMed Web of Science ®Google Scholar
• Engels E. A., Rodman L. H., Frish M., Goedert J. J., Biggar R. J. Childhood exposure to simian virus 40 contaminated poliovirus vaccine and risk of AIDS associated non-Hodgkin's lymphoma. Int. J. Cancer 2003; 106(2)283–287, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Engels E. A., Katki H. A., Nielsen N. M., Winther J. F., Hjalgrim H., Gjernis F., Rosenberg P S, Frish M. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J. Natl. Cancer. Inst. 2003; 95(7)532–539, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Engels E. A., Chen J., Viscidi R. P., Shah K. V., Daniel R. W., Chatterjee N., Klebanoff M. A. Poliovirus vaccination during pregnancy maternal seroconversion to simian virus 40 and risk of childhood cancer. Am. J. Epidemiol. 2004; 160(4)306–316, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rollison D. E., Page W. F., Crawford H., Gridley G., Wacholder S., Martin J., Miller R., Engels E. A. Case control study of cancer among US army veterans exposed to simian virus 40 contaminated adevovirus vaccine. Am. J. Epidemiol. 2004; 160(4)317–324, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Thu G. O., Hem L. Y., Hansen S., Moller B., Norstein J., Nokleby H., Grotmol T. Is there an association between SV40 contaminated polio vaccine and lymphoproliferative disorders? an age period cohort analysis on Norwegian data from 1953 to 1997. Int. J. Cancer. 2005, 10.1002/ijc.21603[CSA]
   Web of Science ®Google Scholar
• Fredericks D. N., Relman D. A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 1996; 9(1)18–33, [CSA]
   PubMed Web of Science ®Google Scholar
• Melnick J. L., Stinebaugh S. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc. Soc. Exp. Biol. Med. 1962; 109: 965–968, [CSA]
   PubMed Web of Science ®Google Scholar
• Cutrone R., Lednicky J., Dunn G., Rizzo P., Bocchetta M., Chumakov K., et al. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer. Res. 2005; 65(22)10273–10279, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vilchez R. A., Brayton C., Wong C., Zanwar P., Killen D. E., et al. Differential ability of two simian virus 40 strains to induce malignancies in weanling hamsters. Virology. 2004; 330(1)168–177, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• De Sanjose S., Shah K. V., Domingo-Domenech E., Engels E. A., De Sevilla A. F., et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int. J. Cancer. 2003; 104(4)522–524, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Viscidi R. P., Rollison D. E.M., Viscidi E., Clayman B., Rubalcaba E., Daniel R., Major E. O., Shah K. V. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin. Diagn. Lab. Immunol. 2003; 10(2)278–285, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Carter J. J., Madeleine M. M., Wipf G. C., Garcea R. L., Pipkin P. A., Minor P. O., Galloway D. A. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J. Natl. Cancer. Inst. 2003; 95(20)1522–1530, [CSA]
   PubMed Web of Science ®Google Scholar
• Shah K. V., Galloway D. A., Knowles W. A., Viscidi R. P. Simian virus 40 (SV40) and human cancer: a review of the serological data. Rev. Med. Virol. 2004; 14(4)231–239, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Engels E. A., Chen J., Viscidi R. P., Shah K. V., Daniel R. W., Chatterjee N., Klebanoff M. A. Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer. Am. J. Epidemiol. 2004; 160(4)306–316, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Engels E. A., Viscidi R. P., Galloway D. A., Carter J. J., Cerhan J. R., et al. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J. Natl. Cancer Inst. 2004; 96(18)1368–74, [CSA]
   PubMed Web of Science ®Google Scholar
• Rollison D. E., Helzlsouer K. J., Halsey N. A., Shah K. V., Viscidi R. P. Markers of past infection with simian virus 40 (SV40) and risk of incident non-hodgkin's lymphoma in a Maryland cohort. Cancer Epidemiol Biomarkers Prev. 2005; 14(6)1448–1452, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Imperiale M. J. The human polyomaviruses: an overview. Human Polyomaviruses: Molecular and Clinical Perspectives, K. Khalili, G. L. Stoner. Wiley-Liss, Inc., New York 2001; 53–71
   Google Scholar
• Lundstig A., Eliasson L., Lehtinen M., Sasnauskas K., Koskela P., Dillner J. Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles. J. Gen. Virol. 2005; 86(6)1703–1708, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Arrington A. S., Moore M. S., Butel J. S. SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus. Oncogene. 2004; 23(12)2231–2235, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rizzo P., Carbone M., Fisher S. G., Matker C., Swinnen L. J., et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest. 1999; 116(Suppl 6)470–73, [CROSSREF], [CSA]
   Google Scholar
• David H., Mendoza S., Konishi T., Miller C. W. Simian virus 40 is present in human lymphomas and normal blood. Cancer. Lett. 2001; 162(10)57–64, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Vilchez R. A., Madden C. R., Kozinetz C. A., Halvorson S. J., White Z. S., et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359(9309)817–823, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vilchez R. A., Lednicky J. A., Halvorson S. J., White Z. S., Kozinetz C. A., Butel J. S. Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma. J. Acquir. Immune. Defic. Syndr. 2002; 29(2)109–116, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Shivapurkar N., Harada K., Reddy J., Scheuermann R. H., Xu Y., McKenna R. W., Milchgrub S., Kroft S. H., Feng Z., Gazdar A. F. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet. 2002; 359(9309)851–852, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Shivapurkar N., Takahashi T., Reddy J., Zheng Y., Stastny V., et al. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer. Res. 2004; 64: 3757–3760, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Samaniego F., Wang S., Young D., Wang S. (2004) Large T antigen DNA and protein of simian virus 40 in non-Hodgkin's lymphoma. (Abstract #4762). 95th Annual Meeting of the American Association for Cancer Research, Orlando, FL, March, 27–312004
   Google Scholar
• Vilchez R. A., Lopez-Terrada D., Finch C., Middleton J. R., Killen D. E., et al. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma. Virology 2005; 342(1)38–46, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Martini F., Dolcetti R., Gloghini A., laccheri L., Carbone A., Boiocchi M., Tognon M. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV” and HIV⁁ patients. Int. J. Cancer. 1998; 78(6)669–674, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nakatsuka S.-L, Liu A., Dong Z., Nomura S., Takakuwa T., Miyazato H., Aozasa K. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer. Res. 2003; 63(22)7606–7608, [CSA]
   PubMed Web of Science ®Google Scholar
• Meneses A., Lopez-Terrada D., Zanwar P., Killen D. E., Monterroso V., Butel J. S., Vilchez R. A. Lymphoproliferative disorders in Costa Rica and SV40. Haematologica. 2005; 90(12)1635–1642, [CSA]
   PubMed Web of Science ®Google Scholar
• Heinsohn S., Golta S., Kabisch zur Stadt H., Standardized U. detection of Simian virus 40 by real-time quantitative polymerase chain reaction in pediatric malignancies. Haematologica. 2005; 90(1)95–100, [CSA]
   Google Scholar
• Daibata M., Nemoto Y., Kamioka M., Imai S., Taguchi H. Simian virus 40 in Japanese patients with lymphoproliferative disorders. Br. J. Haematol. 2003; 121(1)190–191, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Capello D., Rossi D., Gaudino G., Carbone A., Gaidano G. Simian virus 40 infection in lymphoproliferative disorders. Lancet. 2003; 361(9351)88–89, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• MacKenzie J., Wilson K. S., Perry J., Gallagher A., Jarrett R. F. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J. Natl. Cancer Inst. 2003; 95(13)1001–1003, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hernandez-Losa J., Fedele C. G., Pozo F., Tenorio A., Fernandez V., Castellvi J., Parada C., Ramon y Cajal S. Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas. Cancer 2005; 103(2)293–298, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Schuler F., Dolken S. C., Hirt C., Dolken M. T., Mentel R., Gurtler L. G., Dolken G. No evidence for simain virus 40 DNA sequences in malignant non-Hodgkin's lymphoma. Int. J. Cancer 2006; 118(2)498–504, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Carbone M., Rdzanek M. A., Rudzinski J. J., De Marco M. A., Bocchetta M., Ramos Nino M., Mossman B., Pass H. I. SV40 detection in human tumor specimens. Cancer. Res. 2005; 65(21)10120–10121, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar